Gardasil on Trial: Did Merck Mislead the Public on Cervical Cancer Prevention?
Top expert delivers a damning report accusing Merck of misleading the public about Gardasil’s ability to prevent cervical cancer.
With the landmark trial against Merck adjourned until September 2025, new evidence suggests the vaccine manufacturer may have deliberately misrepresented the necessity of mass HPV vaccination.